WHO Director Travels to Congo as Ebola Outbreak Worsens

When WHO Director-General Tedros Adhanom Ghebreyesus arrived in the Democratic Republic of Congo in late May 2026, the outbreak he came to assess had already outpaced the international response. Nearly 1,000 suspected Ebola cases had been tallied across three provinces, over 220 people were suspected dead, and the virus had crossed an international border into Uganda [1][2]. On May 17, Tedros took the extraordinary step of declaring the outbreak a Public Health Emergency of International Concern — the WHO's highest alarm — less than two weeks after the virus was even identified [3].

The declaration was unusual not just for its speed, but for its reason. This outbreak is caused by the Bundibugyo ebolavirus, a rare strain first identified in Uganda in 2007. Unlike the Zaire species responsible for the 2014 West African and 2018-2020 Kivu epidemics, the Bundibugyo strain has no licensed vaccine and no virus-specific therapeutics [4][5]. The two approved Ebola vaccines — Merck's Ervebo (rVSV-ZEBOV) and Johnson & Johnson's Zabdeno/Mvabea — were developed specifically against the Zaire species and show little evidence of cross-protection [6].

"This is a catastrophic collision of disease and conflict," Tedros said at a media briefing on May 20. "We cannot build community trust or isolate the sick while bombs are falling" [2].

The Outbreak by the Numbers

As of May 27, 2026, DRC authorities have reported 977 suspected cases with 228 suspected deaths — a suspected case fatality rate of approximately 23% [7]. Uganda has confirmed 7 laboratory-linked cases with 1 death [7]. The total across both countries exceeds 1,200 when including suspected, probable, and confirmed cases reported through various tracking systems [8].

The outbreak's epicenter is Mongbwalu, a gold-mining town of approximately 130,000 people in Ituri Province [9]. From there it has spread to at least 11 health zones across Ituri, North Kivu, and South Kivu provinces [2]. Cases have been confirmed as far as Goma, the regional capital of North Kivu, and Butembo, a densely populated commercial hub [8].

Source: WHO Historical Data

Data as of May 28, 2026CSV

Compared to the 2018-2020 Kivu outbreak — which infected 3,481 people and killed 2,299, making it the deadliest in DRC history — the current outbreak has spread faster in its initial weeks [1][8]. However, the estimated case fatality rate of roughly 22% is significantly lower than the 66% seen during the Kivu crisis or the 36% observed in the only previous Bundibugyo outbreak in 2007 [4]. Epidemiologists caution that the lower rate may partly reflect the large number of unconfirmed suspected cases; the true CFR will only become clear as laboratory confirmation catches up with surveillance [7].

Source: WHO/CDC

Data as of May 28, 2026CSV

A critical factor in the current outbreak's severity is the detection gap. Symptoms were first recorded in Mongbwalu on April 25, but laboratory confirmation of Bundibugyo virus disease did not come until May 15 — a four-week delay during which the virus spread undetected through healthcare facilities and community networks [4].

No Vaccine for This Strain

The absence of a vaccine fundamentally changes the response calculus. During the 2018-2020 Kivu outbreak, ring vaccination with Ervebo — administering the vaccine to contacts and contacts-of-contacts of confirmed cases — proved highly effective and was credited with helping bring the epidemic under control [6]. That tool is not available here.

Merck has confirmed that Ervebo is not approved for the Bundibugyo strain [5]. WHO chief scientist Sylvie Briand said the agency considers Ervebo a poor candidate because "it has very little evidence of cross-protection for Bundibugyo" [6]. A candidate vaccine using the same rVSV platform but targeting the Bundibugyo ebolavirus exists in the research pipeline, but it has not undergone large-scale clinical trials [6].

With no vaccine, contact tracing — identifying and monitoring everyone an infected person has been in contact with — becomes the primary containment tool [7]. But that method depends on community cooperation, functional health infrastructure, and the ability of health workers to move freely through affected areas. In eastern Congo, all three are in short supply.

Conflict and the Collapse of Containment

The outbreak's geographic footprint overlaps with one of the world's most active conflict zones. Confirmed cases have been reported in areas of North Kivu and South Kivu governed by Rwanda-backed M23 rebels, and armed violence in Ituri — including attacks by the Allied Democratic Forces — has restricted health worker access across multiple health zones [9][10].

At least four Ebola treatment centers have been attacked since the outbreak began [7]. WHO has reported that "in many affected areas, health facilities are either non-functional or operating under severe constraints due to insecurity" [7]. Poor road infrastructure further limits the movement of humanitarian personnel and supplies [2].

The security situation has direct consequences for the outbreak response. Contact tracing teams cannot operate in areas controlled by armed groups. Vaccination campaigns — even if a vaccine were available — would face the same access barriers. Healthcare workers, already among the earliest victims of Ebola outbreaks, are working in facilities that are themselves targets.

At least four healthcare workers died within days at Mongbwalu General Referral Hospital at the start of the outbreak, and two healthcare workers in Uganda have been confirmed infected [4][7]. Hospitals have historically served as amplification sites for Ebola, and the pattern is repeating in Ituri.

Community distrust further compounds the problem. Years of conflict and perceived failures by the Congolese government and international organizations have produced widespread suspicion of outside authorities [9]. During the 2018-2020 outbreak, this distrust fueled attacks on Ebola responders and refusal to cooperate with contact tracing. The same dynamics are at play in 2026, with vaccine hesitancy and misinformation circulating through affected communities [9].

The Funding Crisis

The financial architecture of the response is strained by an unprecedented combination of factors. International donors pledged approximately $500 million for the Ebola response through the Africa Centers for Disease Control and Prevention, but actual commitments stand at roughly $290 million — leaving a gap of more than $200 million [11].

The shortfall has been worsened by the withdrawal of the United States from WHO and the dismantling of USAID. Dennis Carroll, former director of USAID's Emerging Pandemic Threats program, told NPR that "no one has stepped in to fill the gap with the departure of the U.S. from WHO and the elimination of foreign assistance programs like USAID" [12].

The U.S. historically provided not just funding but operational expertise. Carroll described the loss in blunt terms: the U.S. possessed a "depth and breadth of expertise" in outbreak response that no other country matched, and the departure eliminated access to "decades of experience, which is critical" in pandemic situations [12]. Pre-existing regional infrastructure for disease surveillance and rapid response — much of it built with U.S. support — lost funding when USAID was dismantled, weakening the detection systems that might have identified the outbreak sooner [12].

During the 2018 Kivu outbreak, the United States contributed over $500 million to the response over its two-year duration and deployed CDC personnel directly to the field [13]. The contrast with the current response — where the U.S. has focused primarily on airport screenings at three domestic airports and a new quarantine protocol routing exposed Americans through Kenya — is stark [7].

Did Capacity Building Fail?

Since the 2018-2020 outbreak, hundreds of millions of dollars flowed into strengthening DRC's domestic public health capacity. The CDC supported the creation of a Field Epidemiology Training Program (FETP), graduating its first class of ten residents in August 2023 [13]. WHO helped strengthen local health authorities' ability to manage outbreaks during the nearly two years of the Kivu response [13]. Genomic surveillance capacity was built within DRC, generating sequences covering approximately 17% of known cases during the Kivu outbreak [13].

Yet the current outbreak raises questions about whether that investment translated into durable capacity. The four-week detection gap suggests that early warning systems did not function as designed. The DRC Ministry of Health did deploy rapid-response teams, but the scale of the outbreak quickly exceeded their capacity [2].

Some epidemiologists argue this framing misses the point. DRC has successfully contained at least 12 smaller Ebola outbreaks since 2018, several within weeks and without international emergency declarations [8]. The difference in 2026 is the convergence of a novel strain with no countermeasures, active armed conflict, and a withdrawal of international support — conditions that would strain any country's public health system.

Regional Spread and Border Responses

The confirmation of seven Ebola cases in Uganda — including cases in the capital, Kampala — triggered a cascade of border measures across East Africa [14][15].

Uganda halted all public transportation between Congo and Uganda for four weeks and suspended cultural celebrations along the border. The country has confirmed cases linked directly to travelers from DRC [14][15].

Rwanda denied entry to all foreign nationals who transited Congo within 30 days and imposed mandatory quarantine on Rwandan residents returning from DRC. Hand-washing stations were installed at markets, churches, and schools along the border [14].

Zambia declared a "very high" threat level due to its 1,000-mile shared border with DRC and deployed fever-detection equipment at entry points, measures reminiscent of COVID-19 protocols [14].

Malawi declared the outbreak a "public health concern" and intensified screening at airports and border crossings while training healthcare workers in Ebola case detection [14].

South Sudan and Burundi have also activated cross-border surveillance, though detailed information on their specific measures remains limited [15].

The economic consequences of border restrictions are already materializing. Truck drivers transporting goods to and from eastern Congo face potential cargo movement restrictions, affecting an estimated 2,500 regional drivers [14]. Eastern DRC's mining sector — the area around Mongbwalu is a significant gold-producing region — depends on cross-border trade routes that now face heightened scrutiny and delays.

The Risk of Global Spread: A Contested Question

The PHEIC declaration and director-level WHO visit have prompted debate among epidemiologists about whether the international alarm is proportionate to the actual risk of global spread.

DRC has experienced at least 17 Ebola outbreaks since the virus was first identified near the Ebola River in 1976 [5]. The vast majority were contained within the country, often within weeks, without director-level international intervention. Even the 2018-2020 Kivu outbreak — which lasted two years and generated over 3,400 cases — produced only a handful of cross-border cases into Uganda and never spread beyond the immediate region.

Proponents of a more measured response point out that Ebola's transmission dynamics — requiring direct contact with bodily fluids — inherently limit its pandemic potential compared to respiratory viruses. Air travel from eastern DRC is limited, and the virus's severe symptoms make asymptomatic spread unlikely.

However, several factors distinguish the 2026 outbreak. The Bundibugyo strain's lack of countermeasures removes the firebreak that ring vaccination provided during Kivu [6]. The confirmed cases in Kampala — a city with an international airport and significantly higher connectivity than rural Ituri — represent a qualitatively different risk profile [7]. The U.S. government, while stepping back from international coordination, has taken the domestic threat seriously enough to institute airport screenings and revise quarantine protocols [7]. Secretary of State Marco Rubio stated: "We cannot and will not allow any cases of Ebola to enter the United States" [7].

The CDC assessed the risk to the general U.S. public as "very low" but advised clinicians to be alert for patients presenting with compatible symptoms and recent travel history to affected areas [16].

Second-Order Health Consequences

Past Ebola outbreaks have demonstrated that the disease's toll extends well beyond its direct victims. When health systems redirect resources toward outbreak response, routine services — vaccination campaigns, malaria treatment, maternal care — suffer.

Research from the 2014 West African outbreak found that the cessation of malaria care during the epidemic increased untreated malaria cases by 45% in Guinea, 88% in Sierra Leone, and 140% in Liberia [17]. The current outbreak is occurring in provinces where nearly 10 million people already face acute hunger [2] and where health services were already strained by conflict-related displacement.

CARE reported that healthcare workers in Ituri are being redirected from routine services to Ebola response. Midwives who normally provide maternal and neonatal care at CARE-supported clinics are now focused on Ebola prevention [18]. The organization warned that for women and girls, the disruption means reduced access to maternal health care, contraception, and gender-based violence prevention services [18].

CARE also noted that U.S. funding cuts "significantly reduced operational capacity in DRC, weakening critical community-level disease surveillance and preparedness systems" — systems that serve dual purposes for both outbreak response and routine healthcare delivery [18].

The 26.5 million people facing acute food insecurity nationally [2] add another layer of vulnerability. As Tedros observed: "People weakened by hunger are far more vulnerable to infections" [2]. Malnourished patients who contract Ebola face worse outcomes, and communities already struggling with food security are less able to comply with quarantine measures that disrupt subsistence activities.

What Comes Next

The trajectory of the 2026 outbreak depends on several variables that remain unresolved. Can contact tracing teams gain access to conflict-affected zones? Will the candidate Bundibugyo vaccine advance quickly enough to be deployed under emergency-use protocols? Will donor commitments close the $200 million funding gap?

The WHO Emergency Committee's temporary recommendations, issued May 22, called on DRC and Uganda to strengthen surveillance, improve laboratory confirmation capacity, and ensure that response activities are integrated with — not substitutes for — existing health services [19]. The committee also urged member states to avoid trade and travel restrictions beyond what the International Health Regulations authorize.

For now, the outbreak continues to outpace the response. Each day that passes without effective countermeasures increases the risk of further geographic spread, additional healthcare worker infections, and deeper damage to an already fragile health system. The WHO Director-General's presence in Congo is both a signal of urgency and an implicit acknowledgment that the international community's investments in pandemic preparedness have not yet met this moment.